Medical specialists from Canada tagged as investigators in clinical trials studying Inflammatory Breast Neoplasms
Total 3 results
-
Eileen RakovitchSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
- Ontario, Toronto, Sunnybrook Health Sciences Centre - Odette Cancer Centre
Trials:- NCT04228991 (Principal Investigator)
- NCT03488693 (Principal Investigator)
- NCT03598257 (Principal Investigator)
- NCT04852887 (Principal Investigator)
-
Muhammad SalimSeen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:- NCT03763604 (Principal Investigator)
- NCT03598257 (Principal Investigator)
- NCT02488967 (Principal Investigator)
Conditions:- Metastatic Breast Cancer;
- Breast Inflammatory Carcinoma;
- Stage IIIA Breast Cancer;
- Stage IB Breast Cancer;
- Stage IIA Breast Cancer;
- Stage IIB Breast Cancer;
- Stage IIIC Breast Cancer;
- Estrogen Receptor Negative;
- HER2/Neu Negative;
- Progesterone Receptor Negative;
- Triple-Negative Breast Carcinoma;
- Breast Adenocarcinoma
-
Thierry M. MuanzaSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT03550391 (Principal Investigator)
- NCT03488693 (Principal Investigator)
- NCT03598257 (Principal Investigator)
Conditions:
Clinical Trials on Inflammatory Breast Neoplasms
-
National Cancer Institute (NCI)RecruitingBreast Inflammatory CarcinomaUnited States, Canada, Puerto Rico
-
NYU Langone HealthCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationActive, not recruitingInflammatory Breast Cancer (IBC)United States
-
BerGenBio ASAMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IVSpain, United States, United Kingdom, Norway
-
M.D. Anderson Cancer CenterActive, not recruitingBreast Inflammatory Carcinoma | Recurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
National Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Inflammatory CarcinomaUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel, Spain, Australia, Canada, New Zealand, United Kingdom, France, Tunisia